BRIEF published on 03/24/2026 at 07:05, 1 month 17 days ago Curatis Reports Significant Revenue Growth and Progress in Corticorelin Development Financial Results Revenue Growth FDA Approval Curatis Corticorelin
BRIEF published on 03/24/2026 at 07:05, 1 month 17 days ago Curatis annonce une croissance significative de son chiffre d'affaires et des progrès dans le développement de la corticoréline. Résultats Financiers Croissance Des Revenus Curatis Approbation De La FDA Corticoréline
BRIEF published on 03/24/2026 at 07:05, 1 month 17 days ago MCH Group Achieves Profitability Improvement in 2025 Financial Performance Profitability Strategic Growth Art Basel New Platforms
BRIEF published on 03/24/2026 at 07:05, 1 month 17 days ago Le groupe MCH enregistre une amélioration de sa rentabilité en 2025 Rentabilité Performance Financière Croissance Stratégique Art Basel Nouvelles Plateformes
BRIEF published on 03/24/2026 at 07:05, 1 month 17 days ago Branicks Group AG Achieves Top ESG Ratings Real Estate Sustainability Morningstar Sustainalytics ESG Ratings Branicks Group
BRIEF published on 03/24/2026 at 07:05, 1 month 17 days ago Branicks Group AG obtient les meilleures notes en matière d'ESG Immobilier Durabilité Morningstar Sustainalytics Groupe Branicks Évaluations ESG
BRIEF published on 03/24/2026 at 07:05, 1 month 17 days ago Renouvellement de la période d'observation pour BIOSYNEX Reorganisation Réduction Des Coûts BIOSYNEX Sauvegarde Plan D'apurement
BRIEF published on 03/24/2026 at 07:05, 1 month 17 days ago Renewal of the observation period for BIOSYNEX Reorganization Cost Reduction Backup BIOSYNEX Debt Repayment Plan
BRIEF published on 03/24/2026 at 07:05, 1 month 17 days ago Newron Announces 2025 Results and 2026 Outlook Financial Results Schizophrenia Treatment Patent Grant 2026 Outlook Evenamide Trials
BRIEF published on 03/24/2026 at 07:05, 1 month 17 days ago Newron annonce ses résultats pour 2025 et ses perspectives pour 2026. Résultats Financiers Traitement De La Schizophrénie Perspectives Pour 2026 Brevet Accordé Essais Sur L'Evenamide
Published on 05/09/2026 at 01:30, 1 day 13 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 14 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 14:00, 40 minutes ago MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 2 hours 55 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 19 hours 35 minutes ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 18 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 19 hours ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/07/2026 at 19:15, 2 days 19 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 19 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 19 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 19 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 19 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
